Methylome Analyses Implicate Fallopian TubeEpithelia as theOrigin forHigh-GradeSerous Ovarian Cancer

High-grade serous ovarian cancer (HGSC) is themost common and lethal form of epithelial ovarian cancer (EOC). Two distinct tissues have been suggested as the tissue of origin: ovarian surface epithelia (OSE) and fallopian tube epithelia (FTE). We hypothesized that the DNA methylome of HGSC should more closely resemble the methylome of its tissue of origin. To this end, we profiled HGSC (n1⁄4 10), and patient-matched OSE and FTE (n1⁄4 5) primary fresh-frozen tissues, and analyzed the DNA methylome using Illumina 450K arrays (n1⁄4 20) and Agilent Sure Select methyl-seq (n 1⁄4 7). Methylomes were compared using statistical analyses of differentially methylated CpG sites (DMC) and differentially methylated regions (DMR). In addition, methylation was evaluated within a variety of different genomic contexts, including CpG island shores and Homeobox (HOX) genes, due to their roles in tissue specification. Publicly available HGSC methylome data (n 1⁄4 628) were interrogated to provide additional comparisons with FTE and OSE for validation. These analyses revealed that HGSC and FTE methylomes are significantly and consistentlymore highly conserved than areHGSCand OSE. Pearson correlations and hierarchal clustering of genes, promoters, CpG islands, CpG island shores, and HOX genes all revealed increased relatedness of HGSC and FTE methylomes. Thus, these findings reveal that the landscape of FTEmore closely resembles HGSC, the most common and deadly EOC subtype. Implications: DNA methylome analyses support the hypothesis that HGSC arise from the fallopian tube and that due to its tissuespecificity and biochemical stability, interrogation of the methylomemaybe a valuable approach to examine cell/tissue lineage in cancer. Mol Cancer Res; 14(9); 1–8. 2016 AACR.

[1]  R. Ganapathi,et al.  Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer. , 2016, Gynecologic oncology.

[2]  Elvio G. Silva The Origin of Epithelial Neoplasms of the Ovary: An Alternative View , 2016, Advances in anatomic pathology.

[3]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[4]  N. Barker,et al.  Ovary and fimbrial stem cells: biology, niche and cancer origins , 2015, Nature Reviews Molecular Cell Biology.

[5]  Zhaohui S. Qin,et al.  Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates , 2015, Nucleic acids research.

[6]  Joshy George,et al.  Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.

[7]  Matthew D. Schultz,et al.  Human Body Epigenome Maps Reveal Noncanonical DNA Methylation Variation , 2015, Nature.

[8]  D. Zack,et al.  Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation , 2015, BMC Genomics.

[9]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[10]  D. Matei,et al.  The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer , 2014, Clinical Cancer Research.

[11]  Thomas Lengauer,et al.  Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.

[12]  R. Mägi,et al.  DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns , 2014, Genome Biology.

[13]  K. Odunsi,et al.  LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. , 2014, Gynecologic oncology.

[14]  Gregory A. Wyant,et al.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer Cell.

[15]  R. Drapkin,et al.  Coming into focus: the nonovarian origins of ovarian cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[17]  Z. Dezső,et al.  Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer , 2013, International journal of molecular sciences.

[18]  D. Zack,et al.  A novel methyl-binding domain protein enrichment method for identifying genome-wide tissue-specific DNA methylation from nanogram DNA samples , 2013, Epigenetics & Chromatin.

[19]  W. Reik,et al.  Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[20]  Helene Myrtue Nielsen,et al.  DNA methylation based biomarkers: practical considerations and applications. , 2012, Biochimie.

[21]  Colm E. Nestor,et al.  Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns , 2012, Genome Biology.

[22]  Tuan V. Nguyen,et al.  Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. , 2012, Gynecologic oncology.

[23]  Trupti Joshi,et al.  Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing , 2011, Nucleic acids research.

[24]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[25]  H. Nagase,et al.  Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development , 2011, BMC Genomics.

[26]  Felix Krueger,et al.  Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..

[27]  V. Corces,et al.  Enhancer function: new insights into the regulation of tissue-specific gene expression , 2011, Nature Reviews Genetics.

[28]  K. Odunsi,et al.  Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage , 2011, Clinical Cancer Research.

[29]  Ie-Ming Shih,et al.  The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.

[30]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[31]  Martin J. Aryee,et al.  Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.

[32]  R. Drapkin,et al.  Ovarian Cancer Pathogenesis: A Model in Evolution , 2009, Journal of oncology.

[33]  Rafael A. Irizarry,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[34]  R. Drapkin,et al.  Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer , 2007, Clinical Medicine & Research.

[35]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[36]  E. Li,et al.  DNA methylation regulates long-range gene silencing of an X-linked homeobox gene cluster in a lineage-specific manner. , 2006, Genes & development.

[37]  Gordon B Mills,et al.  Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.

[38]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[39]  B. Vanderhyden,et al.  Models of ovarian cancer—Are we there yet? , 2005, Molecular and Cellular Endocrinology.

[40]  Jean-François Ethier,et al.  Reproductive Biology and Endocrinology Open Access Animal Models of Ovarian Cancer , 2022 .

[41]  P. V. van Diest,et al.  Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.

[42]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Mok,et al.  The biology of ovarian cancer. , 1998, Seminars in oncology.

[44]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.

[45]  Neal P. Kawas,et al.  Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. , 2014, Human molecular genetics.

[46]  P. Holland,et al.  Evolution of homeobox genes , 2013, Wiley interdisciplinary reviews. Developmental biology.

[47]  M. Widschwendter,et al.  Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.

[48]  K. Odunsi,et al.  DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. , 2007, Cancer immunity.

[49]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.